| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BOBULSKY SUSAN | Chief Commercial Officer, MRD | C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1165 EASTLAKE AVENUE EAST, SEATTLE | Susan Bobulsky by Kyle Piskel, Attorney-in-Fact | 06 Mar 2026 | 0001820885 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADPT | Common Stock | Award | +59,375 | +17% | $0.000000* | 406,613 | 04 Mar 2026 | Direct | ||
| transaction | ADPT | Common Stock | Award | +62,500 | +15% | $0.000000* | 469,113 | 04 Mar 2026 | Direct |